Pediatric central nervous system inflammatory demyelination: Acute disseminated encephalomyelitis, clinically isolated syndromes, neuromyelitis optica, and multiple sclerosis

Current Opinion in Neurology

Volumn 22, Issue 3, 2009, Pages 233-240

  Dale, Russell C ^a   Brilot, Fabienne ^a   Banwell, Brenda ^b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Acute disseminated encephalomyelitis; Autoantibodies; MRI neuroimaging; Multiple sclerosis; Pediatric

Indexed keywords

BETA INTERFERON; BIOLOGICAL MARKER; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GLATIRAMER; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; MITOXANTRONE; PREDNISONE;

CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL FEATURE; CLINICALLY ISOLATED SYNDROME; DISEASE ASSOCIATION; DRUG DOSE ESCALATION; ENCEPHALOMYELITIS; HUMAN; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEURITIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PREPUBERTY; RECURRENT DISEASE; REMISSION; REVIEW; RISK FACTOR; TREATMENT FAILURE; TREATMENT RESPONSE;

ADOLESCENT; AGE OF ONSET; BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM; CHILD; DEMYELINATING DISEASES; DIAGNOSIS, DIFFERENTIAL; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; ENVIRONMENT; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; RECURRENCE; SYNDROME;

EID: 67049146595     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e32832b4c47     Document Type: Review

References (57)

1. Dale RC, de Sousa C, Chong WK, et al. Acute disseminated encephalo-myelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 2000; 123 (R 12):2407-2422.
2. Tenembaum S, Chamoles N, Fejerman N. Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology 2002; 59:1224-1231.
3. Krupp LB, Banwell B, Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007; 68 (16Suppl 2):S7-S12. The first consensus definitions for pediatric CNS demyelination.
4. Mikaeloff Y, Suissa S, Vallee L, et al. First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability. J Pediatr 2004; 144:246-252.
5. Dale RC, Pillai SC. Early relapse risk after a first CNS inflammatory demyelination episode: examining International consensus definitions. Dev Med Child Neural 2007; 49:887-893.
6. Neuteboom RF, Boon M, Catsman Berrevoets CE, et al. Prognostic factors after a first attack of inflammatory CNS demyelination in children. Neurology 2008; 71:967-973.
7. Alper G, Heyman R, Wang L. Multiple sclerosis and acute disseminated encephalomyelitis diagnosed in children after long-term follow-up: comparison of presenting features. Dev Med Child Neurol 2008 [Epub ahead of print].
8. Banwell B, Ghezzi A, Bar-Or A, et al. Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol 2007; 6:887-902. Thorough review of pediatric MS, including analysis of previously described 1540 pediatric MS cases.
9. Atzori M, Battistella P, Perini P, et al. Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study. Mult Scler 2009; 15:363-370.
10. Mikaeloff Y, Caridade G, Husson B, et al. Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse. Eur J Paediatr Neurol 2007; 11:90-95.
11. Suppiej A, Vittorini R, Fontanin M, et al. Acute disseminated encephalomyelitis in children: focus on relapsing patients. Pediatr Neurol 2008; 39:12-17.
12. Wilejto M, Shroff M, Buncic JR, et al. The clinical features, MRI findings, and outcome of optic neuritis in children. Neurology 2006; 67:258-262.
13. Alper G, Wang L. Demyelinating optic neuritis in children. J Child Neurol 2009; 24:45-48.
14. Pidcock FS, Krishnan C, Crawford TO, et al. Acute transverse myelitis in childhood: center-based analysis of 47 cases. Neurology 2007; 68:1474-1480. Large experience of pediatric transverse myelitis.
15. Lotze TE, Northrop JL, Hutton GJ, et al. Spectrum of pediatric neuromyelitis optica. Pediatrics 2008; 122:e1039-e1047.
16. McKeon A, Lennon VA, Lotze T, et al. CNS aquaporin-4 autoimmunity in children. Neurology 2008; 71:93-100.
17. Banwell B, Tenembaum S, Lennon VA, et al. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology 2008; 70:344-352. NMO-IgG is a specific marker of pediatric NMO.
18. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53:1107-1114.
19. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13:227-231.
20. Boiko A, Vorobeychik G, Paty D, et al. Early onset multiple sclerosis: a longitudinal study. Neurology 2002; 59:1006-1010.
21. Renoux C, Vukusic S, Mikaeloff Y, et al. Natural history of multiple sclerosis with childhood onset. N Engl J Med 2007; 356:2603-2613. Large study of long-term outcome and risk of secondary progression in pediatric MS, compared with adult-onset MS.
22. Mikaeloff Y, Caridade G, Assi S, et al. Prognostic factors for early severity in a childhood multiple sclerosis cohort. Pediatrics 2006; 118:1133-1139.
23. Amato MP, Goretti B, Ghezzi A, et al. Cognitive and psychosocial features of childhood and juvenile MS. Neurology 2008; 70:1891-1897.
24. Pohl D, Rostasy K, Reiber H, Hanefeld F. CSF characteristics in early-onset multiple sclerosis. Neurology 2004; 63:1966-1967.
25. Banwell B, Shroff M, Ness JM, et al. MRI features of pediatric multiple sclerosis. Neurology 2007; 68 (16 Suppl 2):S46-S53.
26. Callen DJ, Shroff MM, Branson HM, et al. MRI in the diagnosis of pediatric multiple sclerosis. Neurology 2009; 72:961-967. New proposed MRI criteria for pediatric MS, yet to be tested in other cohorts.
27. Callen DJ, Shroff MM, Branson HM, et al. Role of MRI in the differentiation of ADEM from MS in children. Neurology 2009; 72:968-973.
28. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50:121-127.
29. Mikaeloff Y, Adamsbaum C, Husson B, et al. MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain 2004; 127 (Pt 9):1942-1947.
30. Pohl D, Waubant E, Banwell B, et al. Treatment of pediatric multiple sclerosis and variants. Neurology 2007; 68 (16 Suppl 2):S54-S65.
31. Hahn JS, Siegler DJ, Enzmann D. Intravenous gammaglobulin therapy in recurrent acute disseminated encephalomyelitis. Neurology 1996; 46:1173-1174.
32. Tenembaum SN, Segura MJ. Interferon beta-1a treatment in childhood and juvenile-onset multiple sclerosis. Neurology 2006; 67:511-513.
33. Ghezzi A, Ruggieri M, Trojano M, Filippi M. Italian studies on early-onset multiple sclerosis: the present and the future. Neurol Sci 2004; 25 (Suppl 4): S346-S349.
34. Banwell B, Reder AT, Krupp L, et al. Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis. Neurology 2006; 66:472-476.
35. Kornek B, Bernert G, Balassy C, et al. Glatiramer acetate treatment in patients with childhood and juvenile onset multiple sclerosis. Neuropediatrics 2003; 34:120-126.
36. Menge T, Kieseier BC, Nessler S, et al. Acute disseminated encephalomye-litis: an acute hit against the brain. Curr Opin Neurol 2007; 20:247-254.
37. Ponsonby AL, van der Mei I, Dwyer T, et al. Exposure to infant siblings during early life and risk of multiple sclerosis. JAMA 2005; 293:463-469.
38. Banwell B, Krupp L, Kennedy J, et al. Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol 2007; 6:773-781.
39. Lunemann JD, Huppke P, Roberts S, et al. Broadened and elevated humoral immune response to EBNA1 in pediatric multiple sclerosis. Neurology 2008; 71:1033-1035.
40. Alotaibi S, Kennedy J, Tellier R, et al. Epstein-Barr virus in pediatric multiple sclerosis. JAMA 2004; 291:1875-1879.
41. Pohl D, Krone B, Rostasy K, et al. High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology 2006; 67:2063-2065.
42. Krone B, Pohl D, Rostasy K, et al. Common infectious agents in multiple sclerosis: a case-control study in children. Mult Scler 2008; 14:136-139.
43. Mikaeloff Y, Caridade G, Assi S, et al. Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination. Brain 2007; 130 (Pt 4):1105-1110.
44. Siegrist CA, Lewis EM, Eskola J, et al. Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions. Pediatr Infect Dis J 2007; 26:979-984.
45. Sutton I, Lahoria R, Tan I, et al. CNS demyelination and quadrivalent HPV vaccination. Mult Scler 2009; 15:116-119.
46. Kampman MT, Wilsgaard T, Mellgren SI. Outdoor activities and diet in childhood and adolescence relate to MS risk above the arctic circle. J Neurol 2007; 254:471-477.
47. Correale J, Tenembaum SN. Myelin basic protein and myelin oligodendrocyte glycoprotein T-cell repertoire in childhood and juvenile multiple sclerosis. Mult Scler 2006; 12:412-420.
48. Banwell B, Bar-Or A, Cheung R, et al. Abnormal T-cell reactivities in childhood inflammatory demyelinating disease and type 1 diabetes. Ann Neurol 2008; 63:98-111.
49. Breij EC, Brink BP, Veerhuis R, et al. Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann Neurol 2008; 63:16-25.
50. Hinson SR, Roemer SF, Lucchinetti CF, et al. Aquaporin-4-binding autoanti-bodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med 2008; 205:2473-2481. A novel method using native conformational MOG shows pediatric CNS demyelination patients have a more pronounced anti-MOG response compared with adult MS and controls.
51. O'Connor KC, McLaughlin KA, De Jager PL, et al. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med 2007; 13:211-217.
52. Dale RC, Church AJ, Cardoso F, et al. Poststreptococcal acute disseminated encephalomyelitis with basal ganglia involvement and auto-reactive antibasal ganglia antibodies. Ann Neurol 2001; 50:588-595.
53. Dale RC, Morovat A. lnterleukin-6 and oligoclonal IgG synthesis in children with acute disseminated encephalomyelitis. Neuropediatrics 2003; 34:141-145.
54. Ishizu T, Minohara M, Ichiyama T, et al. CSF cytokine and chemokine profiles in acute disseminated encephalomyelitis. J Neuroimmunol 2006; 175:52-58.
55. Martino D, Branson JA, Church AJ, et al. Soluble adhesion molecules in acute disseminated encephalomyelitis. Pediatr Neurol 2005; 33:255-258.
56. Feldman BM, Rider LG, Reed AM, Pachman LM. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 2008; 371:2201-2212.
57. Macdermott EJ, Adams A, Lehman TJ. Systemic lupus erythematosus in children: current and emerging therapies. Lupus 2007; 16:677-683.